Cancer Drug Doxil Receives U.S FDA Approval

by Savitha C Muppala on  February 10, 2013 at 12:14 AM Drug News   - G J E 4
Sun Pharmaceutical Industries Ltd. (SUNP), has received the approval by the U.S FDA for the company's generic version of Johnson & Johnson (JNJ)'s cancer drug Doxil.
Cancer Drug Doxil Receives U.S FDA Approval
Cancer Drug Doxil Receives U.S FDA Approval

The U.S. Food & Drug Administration has permitted the sales of Sun Pharma's version of the drug to help with the treatment of patients with ovarian cancer that has progressed or recurred.

According to statistics, a revenue of nearly $402 million has already been generated for J&J in 2011 .

Market analysts have said that this is a very important approval for Sun Pharma. Indeed, it is the first generic player to get an approval for this drug. It is also expected to enjoy exclusivity for the ensuing months.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like